Verdad Advisers, LP Bausch Health Companies Inc. Transaction History

Verdad Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $1.13 Million - $1.35 Million	-45,000 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$27.43 - $32.7 $5.4 Million - $6.44 Million	-196,807 Reduced 81.39%	45,000 $1.32 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $3.7 Million - $5.11 Million	241,807 New	241,807 $5.03 Million

272

280M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Verdad Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Verdad Advisers, LP with notifications on news.